These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9646062)

  • 1. Effect of a single oral dose of two erythromycin ethylsuccinate formulations on gastric emptying in healthy volunteers: a scintigraphic study.
    Delatour F; Le Guludec D; Caron F; Faurisson F; Torlotin JC; Rouveix B
    Fundam Clin Pharmacol; 1998; 12(3):292-7. PubMed ID: 9646062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients.
    Gonlachanvit S; Hsu CW; Boden GH; Knight LC; Maurer AH; Fisher RS; Parkman HP
    Dig Dis Sci; 2003 Mar; 48(3):488-97. PubMed ID: 12757160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 4 x 250 mg erythromycin on human gastrointestinal transit.
    Ueberschaer B; Ewe K; Alles U; Schmidtmann I
    Z Gastroenterol; 1995 Jul; 33(6):340-4. PubMed ID: 7668024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beings.
    Caron F; Bouaniche M; Delatour F; Ducrotte P; Torlotin JC; Denis P; Humbert G; Rouveix B
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1796-800. PubMed ID: 8843283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids.
    Urbain JL; Vantrappen G; Janssens J; Van Cutsem E; Peeters T; De Roo M
    J Nucl Med; 1990 Sep; 31(9):1490-3. PubMed ID: 2395017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single dose of oral erythromycin on gastric and gallbladder emptying. Simultaneous assessment by ultrasound.
    Arienti V; Magri F; Boriani L; Maconi G; Bassein L; Baraldini M; Marzio L; Gasbarrini G
    Dig Dis Sci; 1994 Jun; 39(6):1309-12. PubMed ID: 8200265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of erythromycin on gastric emptying, duodeno-caecal transit time, gastric and biliopancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers.
    Landry C; Vidon N; Sogni P; Nepveux P; Chaumeil JC; Chauvin JP; Couturier D; Chaussade S
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):797-802. PubMed ID: 7496872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers.
    Choi MG; Camilleri M; Burton DD; Johnson S; Edmonds A
    J Pharmacol Exp Ther; 1998 Apr; 285(1):37-40. PubMed ID: 9535992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in healthy subjects.
    Petrakis IE; Kogerakis N; Vrachassotakis N; Stiakakis I; Zacharioudakis G; Chalkiadakis G
    Abdom Imaging; 2002; 27(3):309-14. PubMed ID: 12173362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia attenuates erythromycin-induced acceleration of liquid-phase gastric emptying of hypertonic liquids in healthy subjects.
    Petrakis IE; Kogerakis N; Prokopakis G; Zacharioudakis G; Antonakakis S; Vrachassotakis N; Chalkiadakis G
    Dig Dis Sci; 2002 Jan; 47(1):67-72. PubMed ID: 11837735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokinetic effects of erythromycin after antimotion sickness drugs.
    Stewart JJ; Wood MJ; Parish RC; Wood CD
    J Clin Pharmacol; 2000 Apr; 40(4):347-53. PubMed ID: 10761161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of erythromycin in gastric emptying of solids and hypertonic liquids in healthy subjects.
    Mantides A; Xynos E; Chrysos E; Georgopoulos N; Vassilakis JS
    Am J Gastroenterol; 1993 Feb; 88(2):198-202. PubMed ID: 8424420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin enhances solid-phase gastric emptying in induced-hyperglycemia in patients with truncal vagotomy and pyloroplasty.
    Petrakis IE; Vrachassotakis N; Vassilakis SJ; Sciacca V; Chalkiadakis G
    Dig Dis Sci; 2000 May; 45(5):937-45. PubMed ID: 10795758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced-hyperglycemia attenuates erythromycin-induced acceleration of hypertonic liquid-phase gastric emptying in type-I diabetic patients.
    Petrakis IE; Chalkiadakis G; Vrachassotakis N; Sciacca V; Vassilakis SJ; Xynos E
    Dig Dis; 1999; 17(4):241-7. PubMed ID: 10754365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
    Lakritz J; Wilson WD; Marsh AE; Mihalyi JE
    Vet Ther; 2002; 3(2):189-95. PubMed ID: 19750750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies.
    Janssens J; Peeters TL; Vantrappen G; Tack J; Urbain JL; De Roo M; Muls E; Bouillon R
    N Engl J Med; 1990 Apr; 322(15):1028-31. PubMed ID: 2320062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.
    MacLaren R; Kuhl DA; Gervasio JM; Brown RO; Dickerson RN; Livingston TN; Swift K; Headley S; Kudsk KA; Lima JJ
    Crit Care Med; 2000 Feb; 28(2):438-44. PubMed ID: 10708180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis.
    Desautels SG; Hutson WR; Christian PE; Moore JG; Datz FL
    Dig Dis Sci; 1995 Jan; 40(1):141-6. PubMed ID: 7821102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers.
    Verhagen MA; Samsom M; Maes B; Geypens BJ; Ghoos YF; Smout AJ
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1077-86. PubMed ID: 9663833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.